Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
about
Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approachesTo subjugate NPY is to improve the quality of life and live longerCentral leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions.Cocaine and amphetamine-regulated transcript may regulate bone remodeling as a circulating molecule.Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation.
P2860
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
@ast
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
@en
type
label
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
@ast
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
@en
prefLabel
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
@ast
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
@en
P1433
P1476
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy
@en
P2093
Pushpa S Kalra
Satya P Kalra
P304
P356
10.1358/DOT.2002.38.11.740201
P577
2002-11-01T00:00:00Z